Recent Blog Posts

View Post: OSCIQ - Oscient Pharmaceuticals Corp (PINK Stock) - Stock Market ...
12 Aug 2009 by Volatile22  
The Company markets two products: ANTARA (fenofibrate) capsules, a cardiovascular product, and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic. ANTARA is approved by the FDA to treat hypercholesterolemia (high ...
View Blog: Stock Market Forum, Penny Stocks, FOREX,... - http://www.stockmarketcats.com/

---

View Post: gemifloxacin
27 Jun 2009 by Mlj  
new page: {{pharmacologybox ...
View Blog: gemifloxacin mesylate, factive^®}} as of june 2009 the application for emea centralised marketing authorisation was withdrawn by the manufacturer. [[ca... new page

---

View Post: Gemifloxacin-Associated Neurotoxicity Presenting as Encephalopathy ...
2 Apr 2009 by Barrett, M. J, Login, I. S  
Gemifloxacin mesylate is a fluoroquinolone approved in 2003 for treatment of mild-to-moderate community-acquired pneumonia and acute exacerbation of chronic bronchitis. Compared with other fluoroquinolones, gemifloxacin possesses ...
View Blog: Annals of Pharmacotherapy current issue - http://www.theannals.com/

---

View Post: Tendon Ruptures – Symptoms, Causes and Treatment
4 Nov 2009
Factive (gemifloxacin mesylate); Levaquin (levofloxacin); Cipro XR and Proquin XR. The above listed antibiotics are used fro the treatment of various diseases like. bronchitis, chlamydia, bacterial infection, pneumonia, urinary tract or ...
View Blog: rogersarkansasattorneys.com - http://www.rogersarkansasattorneys.com/

---

View Post: (CRTX) Cornerstone Therapeutics Wins Factive Rights
Stock Blog Hub
8 Sep 2009 by vitalstocks   ...
View Blog: http://www.stockbloghub.com/

---

View Post: ConforMIS Corrals $50M, Oscient Files for Bankruptcy, Vertex ...
14 Jul 2009 by Rebecca Zacks  
The drug maker also agreed to sell the rights to its antibiotic drug gemifloxacin mesylate (Factive), to a subsidiary of Cary, NC-based Cornerstone Therapeutics (NASDAQ:CRTX) for more than $5 million, and is seeking a buyer for its ...
View Blog: Xconomy Seattle - http://www.xconomy.com/

---